Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Journal of Pharmaceutical Policy and Practice

Aukje K Mantel-Teeuwisse¹  Evans L Sagwa¹  Nunurai C Ruswa¹ 

[1] School of Public Health, University of the Western Cape, Cape Town, South Africa

关键词: Medication safety;    Second-line anti-tuberculosis drugs;    Pharmacovigilance;    Adverse effects;    TB/HIV co-infection;    Namibia;   

DOI  :  10.1186/2052-3211-7-14

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Objectives

To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HIV) co-infection status.

【 授权许可】

Unknown